TransMedics Group, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
TMDX on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
200 Minuteman Road, Andover, MA

Insiders trading volume in the past year

TransMedics Group, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Waleed H. Hassanein President & CEO, Director $92.9M -$27.8M -23% Aug 21, 2024
Edwin M. Kania Jr Director $41.5M May 23, 2024
James R. Tobin Director $28M -$8.11M -22.5% Aug 8, 2024
Nicholas Corcoran SVP of Supply Chain and Operations $3.71M -$2.18M -37% Aug 27, 2024
Tamer I. Khayal Chief Commercial Officer $3.46M -$23.2M -87% Sep 3, 2024
Stephen Gordon Chief Financial Officer $2.9M -$10.3M -78% Jun 3, 2024
Miriam Provost VP, Global Regulatory Affairs $2.1M -$310K -12.8% Dec 13, 2023
David Weill Director $1.52M -$494K -24.5% May 29, 2024
Anil P. Ranganath Senior Vice President, General Counsel and Secretary $1.35M -$748K -35.6% Jun 5, 2024
John F. Sullivan VP of Quality & Engineering $1.29M Aug 30, 2021
John F. Carey VP of Operations $1.27M Feb 1, 2023
Laura Damme VP, Clinical Affairs $512K Feb 20, 2023
Merilee Raines Director $262K May 23, 2024
Stephanie Lovell Director $262K May 23, 2024
Thomas James Gunderson Director $262K May 23, 2024
Edward M. Basile Director $111K -$2.73M -96.1% Aug 6, 2024
Rakesh P. Godhani Chief Digital Officer Aug 4, 2021

Recent Insider Transactions by Companies or Individuals for TransMedics Group, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.